Literature DB >> 19483764

Rapid development of pluripotent stem cells as a potential therapeutic modality.

David A Williams.   

Abstract

Mesh：

Year:  2009        PMID： 19483764      PMCID： PMC2835183          DOI： 10.1038/mt.2009.97

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

1.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

2.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

Review 3.  Upping the ante: recent advances in direct reprogramming.

Authors:  Lars U W Müller; George Q Daley; David A Williams
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

4.  Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Authors:  Keisuke Kaji; Katherine Norrby; Agnieszka Paca; Maria Mileikovsky; Paria Mohseni; Knut Woltjen
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962
  4 in total
  1 in total

Review 1.  Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.

Authors:  Kristina Hug; Göran Hermerén
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.